Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 361-370 of 474 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Early pancreatic cancer detection

    Jacksonville, FL

  2. Immune Response to Antigens

    Jacksonville, FL

  3. Innovative CAR-TIL immunotherapy against melanoma

    Jacksonville, FL

  4. A Survey of Pheochromocytoma and Paraganglioma Patient Environment

    Rochester, MN

  5. Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

    Rochester, MN

  6. Establishment of Preclinical Models from Patients with Gynecological Malignancies

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. A Study to Assess Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally-advanced Breast Cancer

    Scottsdale/Phoenix, AZ

  8. A Study to See if the Depth of Tumor Invasion of Esophageal Carcinoma Predicts Lymph Node Involvement and Cancer Free Survival

    Rochester, MN

  9. Patient Derived Preclinical Models

    Rochester, MN

  10. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC

    Rochester, MN

.

Mayo Clinic Footer